Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: an updated instrumental variable meta-analysis

Menglan Pang, Ling Zhu, Audrey Gabelle, Arie R. Gafson, Robert W Platt, James E Galvin, Pierre Krolak-Salmon, Ivana Rubino, Carl de Moor, Shibeshih Belachew, Changyu Shen
doi: https://doi.org/10.1101/2022.04.01.22273253

Article usage

Article usage: April 2022 to July 2025

AbstractFullPdf
Apr 202252112140
May 2022103030
Jun 2022121130
Jul 202264326
Aug 202212710140
Sep 20221396660
Oct 202266712
Nov 202235310
Dec 202228111
Jan 20233614
Feb 20238315
Mar 202338010
Apr 202330311
May 20231216
Jun 20231144
Jul 2023513
Aug 202316124
Sep 20231644
Oct 20231823
Nov 20231727
Dec 20231526
Jan 20241022
Feb 2024814
Mar 202417513
Apr 202410614
May 20241125
Jun 20241006
Jul 20241239
Aug 202414211
Sep 20241128
Oct 20249134
Nov 202471714
Dec 202471619
Jan 20259217
Feb 202511914
Mar 2025211720
Apr 2025221617
May 2025231819
Jun 2025362014
Jul 2025101
Back to top
Posted April 05, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: an updated instrumental variable meta-analysis
Menglan Pang, Ling Zhu, Audrey Gabelle, Arie R. Gafson, Robert W Platt, James E Galvin, Pierre Krolak-Salmon, Ivana Rubino, Carl de Moor, Shibeshih Belachew, Changyu Shen
medRxiv 2022.04.01.22273253; doi: https://doi.org/10.1101/2022.04.01.22273253
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area